Neoadjuvant chemotherapy is associated with a high rate of perioperative blood transfusion at the time of interval cytoreductive surgery

Neoadjuvant chemotherapy is associated with a high rate of perioperative blood transfusion at the time of interval cytoreductive surgery

Abstract Background The oncologic safety of allogeneic blood transfusion in ovarian cancer patients is unknow. We sought to determine the prevalence and oncologic safety of perioperative allogeneic blood transfusion during interval cytoreduction surgery among women receiving neoadjuvant chemotherapy...

Full description

Bibliographic Details
Main Authors: Kevin W McCool, Emmanuel Sampene, Brock Polnaszek, Joseph Connor, Erin E Medlin, Lisa Barroilhet
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Cancer
Subjects:
Ovarian cancer
neoadjuvant
interval cytoreduction
blood transfusion
Online Access:http://link.springer.com/article/10.1186/s12885-018-4882-8

Internet

http://link.springer.com/article/10.1186/s12885-018-4882-8

Similar Items